¼±Åà - È­»ìǥŰ/¿£ÅÍŰ ´Ý±â - ESC

 
"hormone defect"¿¡ ´ëÇÑ °Ë»ö °á°úÀÔ´Ï´Ù. °Ë»ö °á°ú º¸´Â µµÁß¿¡ Tab ۸¦ ´©¸£½Ã¸é °Ë»ö âÀÌ ¼±Åõ˴ϴÙ.
´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 5
  • ¿µ¹®
    ÇѱÛ
  • composition defect
    ±¸¼º°áÇÔ
  • conduction defect
    ÀüµµÀå¾Ö
  • congenital defect
    ¼±Ãµ°áÇÔ, ¼±Ãµ°á¼Õ(Áõ)
  • congruous field defect
    ÀÏÄ¡½Ã¾ß°á¼Õ
  • conjunction defect
    °áÇÕ°áÇÔ
  • cortical sensory defect
    °ÑÁú°¨°¢°á¼Õ, ÇÇÁú°¨°¢°á¼Õ
  • canalization defect
    °üÇü¼º°áÇÔ
  • defect
    1. °áÇÔ, °á¼Õ(Áõ) 2. Àå¾Ö
  • defect rate
    °áÇÔ·ü
  • differentiation defect
    ºÐÈ­°áÇÔ
  • endocardial cushion defect
    ½É(Àå)³»¸·À¶±â°á¼Õ
  • field defect
    ½Ã¾ß°á¼Õ
  • filling defect
    Ãæ¸¸°á¼Õ
  • fusion defect
    À¶ÇÕ°áÇÔ
  • gene defect
    À¯ÀüÀÚ°á¼Õ
¿¾ ´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 5
  • ¿µ¹®
    ÇѱÛ
  • atrial septal defect
    ½É¹æ»çÀ̸·°á¼Õ, ½É¹æÁ߰ݰá¼Õ
  • atrioventricular canal defect
    ¹æ½Ç°ü°á¼Õ(Áõ)
  • atrioventricular septal defect
    ¹æ½Ç»çÀ̸·°á¼Õ(Áõ), ¹æ½ÇÁ߰ݰá¼Õ(Áõ)
  • auditory defect
    û°¢°á¼Õ
  • biochemical defect syndrome
    »ýÈ­ÇÐÀû°áÇÔÁõÈıº
  • canalization defect
    °üÇü¼º°áÇÔ
  • color vision defect
    »ö°¢°áÇÔ
  • composition defect
    ±¸¼º°áÇÔ
  • conduction defect
    ÀüµµÀå¾Ö
  • congenital defect
    ¼±Ãµ°áÇÔ, ¼±Ãµ°á¼Õ(Áõ)
  • congruous field defect
    ÀÏÄ¡½Ã¾ß°áÇÔ
  • conjunction defect
    °áÇÕ°áÇÔ
  • cortical sensory defect
    °ÑÁú°¨°¢°á¼Õ
  • defect
    °áÇÔ, °á¼Õ(Áõ)
  • defect rate
    °áÇÔ·ü
¿¾ ´ëÇÑÀÇÇù 2 ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 5
  • ¿µ¹®
    ÇѱÛ
  • Growth hormone
    ¼ºÀå(à÷íþ)È£¸£¸ó
  • Hyperglycemic hormone
    Ç÷´ç»ó½Â(úìÓØß¾ã°)È£¸£¸ó
  • ICSH = interstitial cell stimulating hormone
    °£Áú¼¼Æ÷ÀÚ±Ø(Êàòõá¬øàí©Ð½)È£¸£¸ó.
  • ICSH=£¾interstitial cell stimulating hormone
    °£Áú¼¼Æ÷ÀÚ±ØÈ£¸£¸ó.
  • LH = luteinizing hormone
    Ȳüȭ(üÜô÷ûù)È£¸£¸ó.
  • LH= luteinizing hormone
    Ȳüȭȣ¸£¸ó.
  • MEH=£¾melanophore expanding hormone
    ¸á¶ó´Ñ º¸À¯¼¼Æ÷ Áõ·®È£¸£¸ó.
  • TRH => thyrotrophin releasing hormone
    °©»ó¼±ÀÚ±ØÈ£¸£¸ó ºÐºñÈ£¸£¸ó
  • TSH=£¾thyroid stimulating hormone
    °©»ó¼±ÀÚ±ØÈ£¸£¸ó
  • TSH=£¾thyroid stimulating hormone
    °©»ó¼±ÀÚ±ØÈ£¸£¸ó.
  • adrenal corticotropic hormone =ACTH
    ºÎ½ÅÇÇÁúÀÚ±Ø(¡­ô§Ð½)È£¸£¸ó
  • androgenic hormone
    ³²¼ºÈ£¸£¸ó
  • anterior lobe hormone
    ÇϼöüÀü¿±(ù»á÷ô÷îñç¨)È£¸£¸ó.
  • anterior pituitary growth hormone
    ÇϼöüÀü¿±¼ºÀåÈ£¸£¸ó.
  • anterior pituitary-like hormone =APLH
    ÇϼöüÀü¿±¾çÈ£¸£¸ó.
¿¾ ´ëÇÑÀÇÇù 3 ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 5
  • ¿µ¹®
    ÇѱÛ
  • hormone dependent tumor
    È£¸£¸óÀÇÁ¸¼º Á¾¾ç.
  • hormone like action
    È£¸£¸óÀ¯»çÀÛ¿ë(¡­×¾ÞÄíÂéÄ).
  • hormone receptor
    È£¸£¸ó¼ö¿ëü.
  • hormone, ectopic production of
    È£¸£¸ó, À̼Ҽº»ý¼º
  • human pituitary follicle stimulating hormone =HPFSH
    »ç¶÷³úÇϼöü³­Æ÷ÀÚ±ØÈ£¸£¸ó.
  • human pituitary follicle stimulating hormone =HPFSH
    ³úÇϼöü³­Æ÷ÀÚ±ØÈ£¸£¸ó.
  • human pituitary follicle stimulating hormone =hPFSH
    ³úÇϼöü³­Æ÷ÀÚ±ØÈ£¸£¸ó.
  • human thyroid stimulating hormone =HTSH
    »ç¶÷°©»ó¼±ÀÚ±ØÈ£¸£¸ó.
  • human thyroid stimulating hormone =HTSH
    °©»ó¼±ÀÚ±ØÈ£¸£¸ó.
  • hypothalamic hormone
    ½Ã»óÇϺΠȣ¸£¸ó
  • hypothalamic hypophysiotropic hormone
    ½Ã»óÇϺÎ(¼º) Çâ(³ú)Çϼöü¼º È£¸£¸ó .
  • inhibitory hormone
    ¾ïÁ¦(åäð¤)È£¸£¸ó.
  • interstitial cell stimulating hormone =ICSH
    °£Áú¼¼Æ÷ÀÚ±Ø(¡­ô§Ð½)È£¸£ ¸ó.
  • intestinal hormone
    Àå(íó)È£¸£¸ó.
  • lactation hormone =lactogenic h.
    ÃÖÀ¯(õÊêá)È£¸£¸ó.
´ëÇÑÇØºÎÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 5
  • ¿µ¹®
    ÇѱÛ
  • Umbilical cord defect
    ÅÈÁÙ°áÇÔ
    [¿¾ ¿ë¾î] Á¦´ë°áÇÔ
  • Retroplasty defect (Double superior vena cava)
    ÅðÇà°áÇÔ (°ãÀ§´ëÁ¤¸Æ)
    [¿¾ ¿ë¾î] ÅðÇຯ¼º°áÇÔ (°ãÀ§´ëÁ¤¸Æ)
  • Retroplasia defect
    ÅðÇຯ¼º°áÇÔ
    [¿¾ ¿ë¾î] ÅðÇຯ¼º°áÇÔ
  • Metabolic defect of nucleic acid (Purinemia)
    ÇÙ»ê´ë»ç°áÇÔ(Ç»¸°Ç÷Áõ)
    [¿¾ ¿ë¾î] ÇÙ»ê´ë»ç°áÇÔ(Ç»¸°Ç÷Áõ)
  • Meoitic defect
    °¨¼öºÐ¿­°áÇÔ
    [¿¾ ¿ë¾î] °¨¼öºÐ¿­±â°áÇÔ
  • Promeiotic defect
    °¨¼öºÐ¿­ÀÌÀü°áÇÔ
    [¿¾ ¿ë¾î] °¨¼öºÐ¿­Àü°áÇÔ
  • Conjunction defect
    °áÇÕ°áÇÔ
    [¿¾ ¿ë¾î] °áÇÕ°áÇÔ
  • Composition defect
    ±¸¼º°áÇÔ
    [¿¾ ¿ë¾î] ±¸¼º°áÇÔ
  • Simple morphologic defect
    ´Ü¼øÇüŰáÇÔ
    [¿¾ ¿ë¾î] ´Ü¼ø¼ºÇüÅÂÇÐÀû°áÇÔ
  • Defect of embryogenesis
    ¹èÀڹ߻ý°áÇÔ
    [¿¾ ¿ë¾î] ¹èÀÚÇü¼º°áÇÔ
  • Multiple morphologic defect
    º¹ÇÕÇüŰáÇÔ
    [¿¾ ¿ë¾î] ´Ù¹ß¼ºÇüÅÂÇÐÀû°áÇÔ
  • Defect of Integument
    ¿ÜÇǰáÇÔ
    [¿¾ ¿ë¾î] ¿ÜÇǰáÇÔ
  • Genetic defect
    À¯ÀüÀÚ°áÇÔ
    [¿¾ ¿ë¾î] À¯ÀüÇÐÀû°áÇÔ
  • Chorionic defect
    À¶¸ð¸·°áÇÔ
    [¿¾ ¿ë¾î] À¶¸ð¸·°áÇÔ
  • Retrogression defect
    ÅðÇà°áÇÔ
    [¿¾ ¿ë¾î] ÅðÈ­¼º°áÇÔ
´ëÇÑ»ýÈ­ÇкÐÀÚ»ý¹°ÇÐȸ ¿ë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 10 ÆäÀÌÁö: 5
  • ¿µ¹®
    ÇѱÛ
  • somatotropin releasing hormone
    ¼Ò¸¶Å䯮·ÎÇÉ ¹æÃâ(Û¯õó) È£¸£¸ó
  • steroid hormone
    ½ºÅ×·ÎÀ̵å È£¸£¸ó
  • thyroid-stimulating hormone
    °©»ó¼±ÀÚ±Ø (Ë£ßÒàÍí©Ð½) È£¸£¸ó
  • thyrotrophic hormone
    °©»ó¼±ÀÚ±Ø (Ë£ßÒàÍí©Ð½) È£¸£¸ó
  • thyrotropic hormone
    °©»ó¼±ÀÚ±Ø (Ë£ßÒàÍí©Ð½) È£¸£¸ó
  • thyrotropic hormone releasing factor
    °©»ó¼±ÀÚ±Ø(Ë£ßÒàÍí©Ð½) È£¸£¸ó À¯¸®ÀÎÀÚ(ë´×îì×í­)
  • thyrotropin releasing hormone
    ŸÀÌ·ÎÆ®·ÎÇÉ À¯¸®(ë´×î)È£¸£¸ó
  • tissue hormone
    Á¶Á÷(ðÚòÄ)È£¸£¸ó
  • trophic hormone
    ÀÚ±Ø(í©Ð½) È£¸£¸ó
  • vitellogenic hormone
    ³­È²»ý¼º(Õ°üÜßæà÷) È£¸£¸ó
KMLE ÀÇÇоà¾î »çÀü À¯»ç °Ë»ö °á°ú : 5 ÆäÀÌÁö: 5
LHRHR luteinizing hormone-releasing hormone receptor
LRH luteinizing hormone-releasing hormone
LSH lutein-stimulating hormone; lymphocyte-stimulating hormone
LTH lactogenic hormone; local tumor hyperthermia; low temperature holding; luteotropic hormone
MH malignant histiocytosis; malignant hyperpyrexia; malignant hypertension; malignant hyperthermia; mam...
KMLE ÀÚµ¿ÃßÃâ ÀÇÇоà¾î »çÀü À¯»ç °Ë»ö °á°ú : 5 ÆäÀÌÁö: 5
LHRH-A luteinizing hormone releasing hormone agonist
LHRHa leuteinizing hormone-releasing hormone analogue
PTH/PTHrP Parathyroid hormone/parathyroid-hormone-related peptide
GnRH gonadotropin hormone releasing hormone
MSH 1-melanocyte-stimulating hormone
°æºÏ´ë Ä¡°ú´ëÇÐ ±¸°­³»°ú ±³½Ç »çÀü À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 5
  • ¿µ¹®
    ÇѱÛ
    ¼³¸í
  • lutinizing hormone
    Ȳüȭ È£¸£¸ó
  • male hormone
    ³²¼º È£¸£¸ó
    ³²¼º °íȯÀÇ °£ ¼¼Æ÷¿¡¼­ ºÐºñµÇ´Â ¾Èµå·Î°Õ. µ¿¹°ÀÇ ¿õ¼º È£¸£¸ó¿¡ ÇØ´çÇÏ´Â ¼º È£¸£¸óÀ¸·Î¼­, ºÎ¼º±â
  • male sex hormone
    ³²¼º È£¸£¸ó
  • medulloid hormone
    ¼öÁú¾ç È£¸£¸ó
  • melanocyte stimulating hormone
    Èæ»ö ¼¼Æ÷ ÀÚ±Ø È£¸£¸ó
  • melanocyte-stimulating hormone
    Èæ»ö ¼¼Æ÷ ÀÚ±Ø È£¸£¸ó, ¸á¶ó´Ñ ¼¼Æ÷ ÀÚ±Ø È£¸£¸ó
    ³úÇϼöü Áß¿±¿¡¼­ ºÐºñµÇ¸é¼­ ü»ö º¯È­¿¡ °ü°èÇϴ ȣ¸£¸ó. ¸á¶ó³ëÆ®·ÎÇÉ
  • melanophore hormone
    ¸á¶ó³ëÆ÷¸£ È£¸£¸ó
  • melanophorotropic hormone
    ¸á¶ó³ëÆ÷¸£ ģȭ¼º È£¸£¸ó
  • molting hormone
    Å»ÇÇ È£¸£¸ó
  • N-hormone
    N-È£¸£¸ó
    ºÎ½Å ÇÇÁú ³»ºÐºñ È£¸£¸óÀÇ Çϳª.
  • natriuretic hormone
    ³ªÆ®·ý ¹è¼³ Áõ°¡ È£¸£¸ó, ³ªÆ®·ý ¹è¼³ ÃËÁø È£¸£¸ó
  • pancreatic hormone
    ÃéÀå È£¸£¸ó
  • parathyroid hormone
    ºÎ°©»ó¼± È£¸£¸ó
    1. ºÎ°©»ó¼± È£¸£¸óÀÇ ÁÖ¿ä »ý¸®Àû ±â´ÉÀº ´ÙÀ½°ú °°´Ù.
  • parathyroid hormone-related peptide
    ºÎ°©»ó¼± È£¸£¸ó ¿¬°ü ÆéŸÀ̵å
  • peptide hormone
    ÆéƼµå È£¸£¸ó
CancerWEB ¿µ¿µ ÀÇÇлçÀü À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 5
mammotropic hormone <protein> Pituitary lactogenic hormone (23 kD) Synthesised on endoplasmic reticulum bound ribosomes as preprolactin that has an N terminal signal peptide that is cleaved from the mature form. The conversion of preprolactin to prolactin has been much used as an assay for membrane insertion.
(18 Nov 1997)
receptors, corticotropin-releasing hormone Cell surface proteins that bind corticotropin-releasing hormone with high affinity and trigger intracellular changes which influence the behaviour of cells. The corticotropin releasing-hormone receptors on anterior pituitary cells mediate the stimulation of corticotropin release by hypothalamic corticotropin releasing factor. The physiological consequence of activating corticotropin-releasing hormone receptors on central neurons is not well understood.
(12 Dec 1998)
receptors, gastrointestinal hormone Cell surface proteins that bind gastrointestinal hormones with high affinity and trigger intracellular changes influencing the behaviour of cells. most gastrointestinal hormones also act as neurotransmitters so these receptors are also present in the central and peripheral nervous systems.
(12 Dec 1998)
receptors, pancreatic hormone Cell surface proteins that bind pancreatic hormones with high affinity and trigger intracellular changes which influence the behaviour of cells. These include receptors for glucagon (secreted by alpha cells), insulin (secreted by beta cells), somatostatin (secreted by delta cells), and pancreatic peptide (secreted by pp cells). Some of these hormones and receptors also support neurotransmission.
(12 Dec 1998)
receptors, parathyroid hormone Cell surface proteins that bind parathyroid hormone with high affinity and trigger intracellular changes which influence the behaviour of cells. Parathyroid hormone receptors on bone, kidney, and gastrointestinal cells mediate the hormone's role in calcium and phosphate homeostasis.
(12 Dec 1998)
receptors, pituitary hormone Cell surface proteins that bind pituitary hormones with high affinity and trigger intracellular changes influencing the behaviour of cells. Since many pituitary hormones are also released by neurons as neurotransmitters, these receptors are also found in the nervous system.
(12 Dec 1998)
receptors, thyroid hormone Proteins, usually found in the nucleus, that specifically bind thyroid hormones and regulate DNA transcription. These proteins, termed c-erba, are activated by hormones and cause differentiation of erythroid progenitor cells which irreversibly lose proliferative potential. Thus c-erba proteins act as growth suppressors. The c-erba proteins are encoded by at least two genes, c-erba alpha and c-erba beta. Each of these has two isoforms. Mutations in the ligand-binding domain of the beta form causes thyroid hormone resistance syndrome.
(12 Dec 1998)
receptors, thyrotropin-releasing hormone Cell surface receptors that bind thyrotropin releasing hormone (trh) with high affinity and trigger intracellular changes which influence the behaviour of cells. Activated trh receptors in the anterior pituitary stimulate the release of thyrotropin (thyroid stimulating hormone, tsh). Trh receptors on neurons mediate neurotransmission by trh.
(12 Dec 1998)
parathyroid hormone <hormone> A peptide hormone of 84 amino acids (9402 D). Stimulates osteoclasts to increase blood calcium levels, the opposite effect to calcitonin.
(18 Nov 1997)
releasing hormone Hormones produced by the hypothalamus whichstimulate the release of other hormones in the pituitary gland.
(09 Oct 1997)
glycoprotein hormone-specific N-acetylgalactosamine transferase <enzyme> Transfers galnac to the terminal glcnac moieties of glcnac2man3glcnac2asn
Registry number: EC 2.4.1.-
Synonym: ghs-acgalnh2 transferase, glycoprotein hormone galnac transferase, glycoprotein hormone - n-acetylgalactosaminyltransferase
(26 Jun 1999)
melanocyte-stimulating hormone <endocrinology> A releasing hormone produced in the mammalian hypophysis and related structures in lower vertebrates. Made up of _ MSH (1665D), the same as amino acids 1-13 of ACTH and _ MSH (18 amino acids, 22 in humans). Causes darkening of the skin by expansion of the melanophores but its role in mammals is unclear.
Synonym: melanotropin.
Acronym: MSH
(22 Sep 2002)
melanotropin release-inhibiting hormone Inhibits synthesis and release of melanotropin.
Synonym: melanotropin release-inhibiting hormone.
Origin: melanotropin + G. States, stationary, + -in
(05 Mar 2000)
melanotropin-releasing hormone A hexapeptide similar to oxytocin; it stimulates the release of melanotropin.
Synonym: melanotropin-releasing factor, melanotropin-releasing hormone.
Origin: melanotropin + L. Libero, to free, + -in
(05 Mar 2000)
peptide hormone inactivating endopeptidase <enzyme> From xenopus laevis; cleaves at xaa-phe, xaa-leu or xaa-ile bonds where xaa = ser, phe, tyr, his or gly in peptide hormones
Registry number: EC 3.4.24.-
Synonym: phie, xenopus
(26 Jun 1999)
ÀÌ ¾Æ·¡ ºÎÅÍ´Â °á°ú°¡ ¾ø½À´Ï´Ù.
KMLE ¾àǰ/ÀǾàǰ ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 5
  • Á¦Ç°¸í
    ¼ººÐ/ÇÔ·®
    ±¸ºÐ/º¸Çè±Þ¿©
KMLE ¾àǰ/ÀǾàǰ À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 5
  • Á¦Ç°¸í
    ¼ººÐ/ÇÔ·®
    ±¸ºÐ/º¸Çè±Þ¿©
¾Ë±â½¬¿î ÀÇÇпë¾îÇ®ÀÌÁý, ¼­¿ïÀÇ´ë ±³¼ö ÁöÁ¦±Ù, °í·ÁÀÇÇÐ ÃâÆÇ ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 5
¾Ë±â½¬¿î ÀÇÇпë¾îÇ®ÀÌÁý, ¼­¿ïÀÇ´ë ±³¼ö ÁöÁ¦±Ù, °í·ÁÀÇÇÐ ÃâÆÇ À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 5
´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 5
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÀÇÇù Çʼö ÀÇÇпë¾îÁý »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 5
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÀÇÇù Çʼö ÀÇÇпë¾îÁý »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 5
  • ¿µ¹®
    ÇѱÛ
¿¾ ´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 5
  • ¿µ¹®
    ÇѱÛ
¿¾ ´ëÇÑÀÇÇù 2 ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 5
  • ¿µ¹®
    ÇѱÛ
¿¾ ´ëÇÑÀÇÇù 3 ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 5
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÇØºÎÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 5
  • ¿µ¹®
    ÇѱÛ
´ëÇѽŰæ¿Ü°úÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 5
  • ¿µ¹®
    ÇѱÛ
    ÇÑÀÚ
´ëÇѽŰæ¿Ü°úÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 5
  • ¿µ¹®
    ÇѱÛ
    ÇÑÀÚ
´ëÇѱâ»ýÃæÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 5
  • ¿µ¹®
    ÇѱÛ
´ëÇѱâ»ýÃæÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 5
  • ¿µ¹®
    ÇѱÛ
´ëÇÑ»ýÈ­ÇкÐÀÚ»ý¹°ÇÐȸ ¿ë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 5
  • ¿µ¹®
    ÇѱÛ
KI ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 5
  • ¿µ¹®
    ÇѱÛ
KI ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 5
  • ¿µ¹®
    ÇѱÛ
KMLE ÀÇÇоà¾î »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 5
KMLE ÀÚµ¿ÃßÃâ ÀÇÇоà¾î »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 5
ÀÇÇÐ³í¹® ¾àÀÚ(Pubmed/Entrez) °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 5
Çѱ¹Ç¥ÁØÁúº´»çÀκзù ¾àÀÚ ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 5
  • ÄÚµå
    ¿µ¹®
    ÇѱÛ
Çѱ¹Ç¥ÁØÁúº´»çÀκзù ¾àÀÚ À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 5
  • ÄÚµå
    ¿µ¹®
    ÇѱÛ
°æºÏ´ë Ä¡°ú´ëÇÐ ±¸°­³»°ú ±³½Ç »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 5
  • ¿µ¹®
    ÇѱÛ
    ¼³¸í
CancerWEB ¿µ¿µ ÀÇÇлçÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 5
MeSH(Medical Subject Headings) ¸ÂÃã °Ë»ö (http://www.nlm.nih.gov) °á°ú : 0 ÆäÀÌÁö: 5
MeSH(Medical Subject Headings) À¯»ç °Ë»ö (http://www.nlm.nih.gov) °á°ú : 0 ÆäÀÌÁö: 5
¿ÜºÎ ¸µÅ© - Merriam-Webster's ÀÇÇлçÀü ¸ÂÃã °Ë»ö (https://www.merriam-webster.com) °á°ú: 0 ÆäÀÌÁö: 5
¿ÜºÎ ¸µÅ© - Merriam-Webster's ÀÇÇлçÀü À¯»ç °Ë»ö (https://www.merriam-webster.com) °á°ú: 0 ÆäÀÌÁö: 5
¿ÜºÎ ¸µÅ© - A.D.A.M. Medical Encyclopedia ¸ÂÃã °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 5
¿ÜºÎ ¸µÅ© - A.D.A.M. Medical Encyclopedia À¯»ç °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 5
¿ÜºÎ ¸µÅ© - MedlinePlus Health Topics ¸ÂÃã °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 5
¿ÜºÎ ¸µÅ© - MedlinePlus Health Topics À¯»ç °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 5
¿ÜºÎ ¸µÅ© - µå·¯±×ÀÎÆ÷ ¾àÇÐ Á¤º¸ ¸ÂÃã °Ë»ö (http://www.druginfo.co.kr) °á°ú: 0 ÆäÀÌÁö: 5
Á¦Ç°¸í
ÆÇ¸Å»ç
º¸ÇèÄÚµå ¼ººÐ/ÇÔ·®
±¸ºÐ/º¸Çè±Þ¿©
¿ÜºÎ ¸µÅ© - µå·¯±×ÀÎÆ÷ ¾àÇÐ Á¤º¸ À¯»ç °Ë»ö (http://www.druginfo.co.kr) °á°ú: 0 ÆäÀÌÁö: 5
Á¦Ç°¸í
ÆÇ¸Å»ç
º¸ÇèÄÚµå ¼ººÐ/ÇÔ·®
±¸ºÐ/º¸Çè±Þ¿©
¿ÜºÎ ¸µÅ© - WebMD.com Drug Reference ¸ÂÃã °Ë»ö (http://www.webmd.com) °á°ú: 0 ÆäÀÌÁö: 5
¿ÜºÎ ¸µÅ© - WebMD.com Drug Reference À¯»ç °Ë»ö (http://www.webmd.com) °á°ú: 0 ÆäÀÌÁö: 5
¿ÜºÎ ¸µÅ© - Drug.com Drugs by Medical Condition ¸ÂÃã °Ë»ö (http://www.drugs.com) °á°ú: 0 ÆäÀÌÁö: 5
¿ÜºÎ ¸µÅ© - Drug.com Drugs by Medical Condition À¯»ç °Ë»ö (http://www.drugs.com) °á°ú: 0 ÆäÀÌÁö: 5
KMLE À¥ ¿ë¾î ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 5
KMLE À¥ ¿ë¾î À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 5
ÇÑ¿µ/¿µÇÑ »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 5
  • ¿µ¹®
    ÇѱÛ
ÇÑ¿µ/¿µÇÑ »çÀü À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 5
  • ¿µ¹®
    ÇѱÛ
WordNet ÀÏ¹Ý ¿µ¿µ »çÀü °Ë»ö °á°ú : 0 ÆäÀÌÁö: 5
¿ÜºÎ ¸µÅ© - American Heritage Dictionary ¿µ¿µ»çÀü ¸ÂÃã °Ë»ö (https://www.ahdictionary.com) °á°ú: 0 ÆäÀÌÁö: 5
¿ÜºÎ ¸µÅ© - American Heritage Dictionary ¿µ¿µ»çÀü À¯»ç °Ë»ö (https://www.ahdictionary.com) °á°ú: 0 ÆäÀÌÁö: 5
ÅëÇÕ°Ë»ö ¿Ï·á